Cancer treatment starts soon. Can I still ask about fertility preservation?

Yes—ask your treating team now. A cancer-treatment start date is a reason to make the fertility conversation urgent, not a reason to assume it is too late. Whether preservation can safely fit depends on your diagnosis, treatment, current health and available options. Do not postpone treatment or change medicines yourself.

The question is not “cancer care or fertility care?”

A diagnosis can turn the next few weeks into a crowded timetable. Scans, consent, surgery, drug names, transport. Fertility can feel like an inappropriate extra question when the immediate task is getting treatment started. But wanting to understand a future possibility is compatible with taking cancer treatment seriously. You do not have to be trying for a baby, partnered or certain that you want children to raise it.

The useful question is narrower: can the oncology and fertility teams identify a medically acceptable preservation option within the actual treatment window? Our urgent preservation referral guide explains the information they need and the decisions you should not have to coordinate alone.

A referral is not a commitment to freeze

You can say: “I do not know what I want yet, but I do not want this option to disappear without understanding it.” A discussion may lead to sperm, egg or embryo freezing, another specialist option, or a decision that a procedure is not appropriate. It may also lead to you declining preservation. An informed choice is the purpose; banking material is not the only acceptable outcome.

NICE’s 2026 guidance calls for early discussion when a medical condition or treatment threatens fertility, including at the earliest opportunity when treatment is urgent. That is different from waiting until you meet a definition of infertility. A future planner can have a time-sensitive need today.

Why another person’s two-week story is not your timetable

Online experiences can reveal useful questions, but they cannot establish how long it is safe for you to wait. “Two weeks” might describe injections, not the entire referral, assessment, screening, collection and recovery pathway. Guy’s and St Thomas’ describes a longer overall egg-freezing process and notes that sometimes chemotherapy cannot be delayed.

Specialist protocols may allow ovarian stimulation to start without waiting for the next period. That removes one possible scheduling barrier; it does not remove the need to assess safety or guarantee a collection before treatment. For someone producing sperm, banking follows a different pathway. Ask the teams for an individual timeline rather than importing an egg-freezing timetable into a sperm-banking decision.

What a useful handover looks like

Ask the referring team to send the proposed regimen or surgery, start date, relevant medical details and the responsible clinician’s contact information. Ask who will confirm that a preservation plan fits the treatment schedule. If two services give different advice, the next step is a conversation between them—not you deciding whose deadline to ignore.

Keep a short note with three lines: the planned treatment date; the fertility decision still open; the named person coordinating it. If you have not received an appointment, use the contact and timeframe your team gives you to check that the referral has reached the right service. You should not need a perfect medical folder to start that conversation.

Men and people without a partner belong in this conversation

Sperm preservation is a person’s own future-health decision, not merely support for a partner. Difficulty producing a sample should be raised promptly so the clinic can assess appropriate help. Being single does not prevent a discussion about storing eggs or sperm. Same-sex family-building plans, donor routes and gender-affirming care also need an individual conversation based on the reproductive material involved and the person’s priorities.

Practical access matters too. Tell the team if you need an interpreter, privacy, help understanding consent or a trusted person at the appointment. An urgent pathway should still make room for informed decisions.

Do not let optimisation become another delay

This is not the moment to wait for a home test, start a supplement programme or try to improve a number before asking about referral. Tests may be part of specialist planning, but an ordinary test cannot certify that a cancer regimen will leave future fertility unchanged. Freezing also cannot guarantee parenthood.

ProFertility’s role is to make these distinctions understandable: what the treatment may affect, what information matters and what action belongs with which team. When cancer treatment is approaching, the immediate route is your treating team and the appropriate preservation service. For the practical checklist, option comparison and consent questions, read Urgent Fertility Preservation Before Cancer Treatment. For the wider picture, see preservation before medical treatment.

Sources and evidence

Sources checked 2 November 2026. These are clinical guidance and patient-information sources, not evidence that every option is safe or available for every diagnosis.

• NICE NG257 — fertility preservation for medical indications (31 March 2026)
• ASRM — Fertility preservation in patients with medical indications (2026 committee opinion)
• ASCO — Fertility Preservation in People With Cancer (2025; published online 19 March)
• HFEA — Fertility preservation (accessed 2 November 2026)
• Guy’s and St Thomas’ — Freezing eggs or embryos (reviewed July 2024; current patient information)